Developing and implementing differentiated strategies that start with our customer, to achieve short and long term global business objectives across a diverse platform ecosystem, including multiomics & clinical diagnostics.Lead the Global organization focused on building a dynamic ecosystem of products and solutions through scouting, partner identification, negotiation & execution of high-value strategic partnerships in tandem with our Product teams. Our objective is to deliver substantial topline growth over the next 5 years. Team has built a partner funnel of over 100 candidate partnerships for organizational consideration.Established the mission, operational & governance models as well as the organizational structure to deliver on essential commercial & partnering objectives, while keep the customer as our North Star. Implemented the foundational architecture for deal execution globally across all 4 major regions for localization.Actively oversaw the successful negotiation & execution of key partnerships & acquisitions to augment portfolio offering and create a differentiated sales bag. Specifically delivered value-add partnerships that drive over $100m in annual sales.

Led a team of strategic marketers to define & win in strategic market segments-Identified portfolio gaps across the diagnostic continuum (systems, reagents, software & digital decision support)-Defined a M&A and partnership funnel based on segmentation analysis for customer needs resulting in acquisition of novel chemistry to unlock >$1b testing market opportunity.-Established a Corporate Competitive Intelligence program to inform segment strategies, positioning & messaging-Defined key points of evidence & study needs to drive solution selling in target segmentsLed a cross-functional, corporate-wide program focusing on customer-centric needs & solutions within the Point-of-Care diagnostics spaceEstablished a high medical value roadmap by leveraging patient & provider-centric insightsLeveraged my in-depth knowledge of the global diagnostic/genomic testing business, especially with regard to R&D, product development, regulatory issues, commercialization, reimbursement initiatives, competition & market trends

Led B2B C-suite engagement to position Roche as the partner of choice in Sequencing & Molecular Diagnostics-Identified novel external technologies for strategic partnerships, acquisitions and in-licensing opportunities-Established & led cross-functional teams for execution of highly synergistic, multi-million dollar deals-Negotiated complex deal structures with partners to ensure commercial success and mitigate potential litigation, resulting in preservation of over $1.375b in cumulative 5-year revenues.-Acted as a partner advocate to drive internal decision making-Created customer & patient-focused partnering strategies to augment the Roche portfolioSuccess in role relied on interpretation of complex data sets (scientific, business, and financial), clinical trial designs and scientific or clinical publications.

Owned & presented Executive-level strategies to justify >$500m investment in the overall program to address a rapidly growing NGS market. Drove cross-functional teams to deliver solutions that simplify complex testing workflows for key customers, resulting in better patient care and reducing healthcare costs. Created robust and innovative business strategies to address customer needs through lifecycle management & pipeline management.

Developed and led a cross-functional team focused on delivering launch excellence in IT solutions for healthcare. Developed and oversaw the execution of breakthrough development and commercial strategies that have led to long-term, sustainable success of multiple products

Drove a cross-functional team focused on portfolio expansion and serve as a key interface with C-Suite executives in 3rd party organizations, leading to strategic long-term relationship development. Led launch planning & management through consistent leadership of global project teams.Drove strategic customer development in Reference Labs, Academic Medical Centers & Core Lab environments to establish rapid product uptake. Resulted in more than 100 high-throughput instrument installations in the first year post-launch.Rapidly assimilated customer needs into our product development process to ensure the customer was positioned at the project team level.

Developed & implemented all commercial activities related to the launch of testing systems and complement assays, including: Pre-Launch Market Development, Competitive Positioning & Messaging, and Sales Training Implementation. Responsible for commercially launching 2 systems (cobas 6800/8800 Systems) and 4 viral load monitoring assays (cobas HIV-1, cobas HCV, cobas HBV and cobas CMV) into the CE-IVD market

Led strategic selling activities for key corporate B2B relationships. Fostered a partnership selling strategy that led to considerable financial results & increased the long-term sustained success of multiple custom products. Direct management of over $40M in annual revenue with expansion to over $120M over the course of a 2 year period.

-Built and managed strategic alliances to augment development efforts for Companion Diagnostic product.-Provided critical data and publication strategy for commercialization of the Companion Diagnostic for cell therapy-Drove product commercialization strategy through development of key regulatory filings (i.e. DMF and EMEA Master File) leading to Phase I Clinical Trial.-Developed KOLs to drive Go-To Market Strategy and new product adoption.-Managed product development from Research to full commercialization. -Established value-based pricing strategy for new products. Negotiated with 3rd party vendors to drive COGS lower, resulting in <80% margin.

Served as Clubs Executive for the Flex-Time Leadership Board. Also served as President of a Management Game team that succeeded in delivering value to shareholders. Focus on Quantitative Analysis, Marketing, and Organizational Behavior. Developed proficiency in SAS Forecasting, Multivariate Regression Modeling of market data, and utilization of optimization techniques in pricing strategies. Participated in pro bono strategic marketing project for two organizations resulting in presentation to the Board of Directors.

Developed a 3-year strategic marketing plan to refine brand identity, increase brand awareness, and instigate increased fundraising for health and educational services in South Africa. Performed quantitative and qualitative marketing research, including expert interviews, to define current barriers to success. Use research and analysis to determine location of current AFPT products in the overall product lifecycle in order to better focus resources on areas of growth. Resulted in presentation of the plan to the Board of Directors.

Developed and tested novel hypotheses regarding the presence of Cancer Stem Cells in Head and Neck Cancer. Awarded a National Research Service Award (NRSA) for Postdoctoral Fellows for work on HER family interactions in Head and Neck Cancer. Worked to manage the academic side of strategic research alliances with two biopharmaceutical companies.Established deadlines and organized meetings with sponsors. Determined efficacy of Tarceva, Cetuximab, and other early stage EGFR TKI therapies in models of HNSCC tumor development based on EGFR mutations.

Facilitated mass end-user pc migration from Y2K non-compliant to Y2K compliant PCs. Provided at-site end user support. Developed and maintained division-wide IT inventory.